Envoy Medical, Inc. (COCH) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 15 transactions totaling $28.5K, demonstrating a bullish sentiment with $28.5K in net insider flow. The most recent transaction on Feb 5, 2026 involved a transaction of 200,000 shares valued at $0.
No significant insider buying has been recorded for COCH in the recent period.
No significant insider selling has been recorded for COCH in the recent period.
Based on recent SEC filings, insider sentiment for COCH is bullish with an Insider Alignment Score of 100/100 and a net flow of $28.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Envoy Medical, Inc. (COCH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading COCH stock, having executed 15 transactions in the past 90 days. The most active insider is Brent T. Lucas (Executive), who has made 6 transactions totaling $24.8K.
Get notified when executives and directors at COCH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | T. Lucas Brent | Executive | Award | 200,000 | $N/A | $0 | |
| Feb 5, 2026 | Potashnick Robert | Interim CFO | Award | 15,000 | $N/A | $0 | C-Suite |
| Nov 28, 2025 | T. Lucas Brent | Executive | Award | 18,105 | $0.71 | $12.9K | |
| Sep 11, 2024 | Chetan Patel Mona | Executive | Purchase | 4,000 | $3.33 | $13.3K | |
| Sep 9, 2024 | Chetan Patel Mona | Executive | Purchase | 1,000 | $3.20 | $3.2K | |
| Jun 24, 2024 | T. Lucas Brent | Executive | Other | 10,176 | $N/A | $0 | |
| Jun 24, 2024 | T. Lucas Brent | Executive | Other | 74,784 | $N/A | $0 | |
| Nov 21, 2023 | T. Lucas Brent | Executive | Purchase | 2,380 | $0.92 | $2.2K | |
| Nov 21, 2023 | T. Lucas Brent | Executive | Purchase | 10,000 | $0.98 | $9.8K | |
| Sep 29, 2023 | L. Dewbrey Diane | Executive | Conversion | 25,000 | $N/A | $0 | |
| Sep 29, 2023 | J. Hirsch Daniel | Executive | Conversion | 25,000 | $N/A | $0 | |
| Sep 29, 2023 | Kantor Susan | Executive | Conversion | 25,000 | $N/A | $0 | |
| Sep 29, 2023 | Cherian Huskins Priya | Executive | Conversion | 25,000 | $N/A | $0 | |
| Sep 29, 2023 | Gp I. Llc Anzu Spac | Executive | Conversion | 2,490,000 | $N/A | $0 | |
| Sep 29, 2023 | Gp I. Llc Anzu Spac | Executive | Other | 490,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 4 | $28.5K | 68.9% |
Award(A) | 3 | $12.9K | 31.1% |
Other(J) | 3 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insiders at Envoy Medical, Inc. are accumulating shares at an accelerated pace. With 8 insiders making 15 transactions totaling $28.5K in purchases versus $0 in sales, the net buying activity of $28.5K signals strong executive confidence. Brent T. Lucas (Executive) leads the buying activity with $24.8K in transactions across all time.